Advancing Drug Development and Outcomes Research with Artificial Intelligence, Machine Learning, and Predictive Models
Richard Gliklich, MD, Founder and CEO, OM1
The convergence of AI, machine learning, predictive modeling and big data enable the ability to measure, predict and personalize care in a way previously not possible. Join Dr. Richard Gliklich, CEO of OM1, as he explores the applications of AI tools and models to accelerate research, measure and benchmark outcomes, and demonstrate value.